SFX by Ex Libris Inc.

Title:	CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire
Source:	Blood [0006-4971] Suessmuth, Yvonne yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gajewski, Thomas F. "Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity." Nature 523.7559 (2015): 231-235.
description	2.	West, A. "PD-1 blockade induces responses by inhibiting adaptive immune resistance." Nature 515.7528 (2014): 568-571.
description	3.	Teira, P. "Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis." Blood 127.20 (2016): 2427-2438.
description	4.	Furman, D. "Cytomegalovirus infection enhances the immune response to influenza." Science translational medicine 7.281 (2015): 281-281.
description	5.	Green, Margaret L. "CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia." Blood 122.7 (2013): 1316-1324.
description	6.	Spranger, S. "Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy." Cancer cell 31.5 (2017): 711-7230000.
description	7.	Harris, B H L H. "Gene Expression Signatures as Biomarkers of Tumour Hypoxia." Clinical oncology 27.10 (2015): 547-560.
description	8.	Ribas, B. "Excluding T Cells: Is β-Catenin the Full Story?" Cancer cell 27.6 (2015): 749-50.
description	9.	Corrales, L. "Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity." Cell Reports 11.7 (2015): 1018-30.
description	10.	Herbst, Roy S. "Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients." Nature 515.7528 (2014): 563-7.
description	11.	Reeves, M. "The pathogenesis of human cytomegalovirus." The Journal of pathology 235.2 (2014): 288-297.
description	12.	Robert, C. "Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial." Lancet (London, England) 384.9948 (2014): 1109-17.
description	13.	Galon, J. "Type, density, and location of immune cells within human colorectal tumors predict clinical outcome." Science 313.5795 (2006): 1960-4.
description	14.	Elmaagacli, Ahmet H. "Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients." Blood 118.5 (2011): 1402-1412.
description	15.	Schwaitzberg, Steven D. "Natural orifice translumenal endoscopic surgery (NOTES): emerging trends and specifications for a virtual simulator." Surgical Endoscopy 30.1 (2016): 190-198.
description	16.	Frasca, D. "Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine." Vaccine 33.12 (2015): 1433-1439.
description	17.	Boyiadzis, M. "Impact of chronic graft-versus-host disease on late relapse and survival on 7489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia." Clinical cancer research 21.9 (2014): 2020-8.
description	18.	Manjappa, S. "Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen." Biology of blood and marrow transplantation 20.1 (2014): 46-52.
description	19.	Olive, B. "Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen." Bone marrow transplantation (2004): 839-846.
description	20.	Fierabracci, A. "Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity." Autoimmunity reviews 10.3 (2011): 137-43.